Related Experiment Video
Updated: Oct 31, 2025
05:59
An In Vitro Dissolution Determination of Multi-Index Components in Tibetan Medicine Rhodiola Granules
Published on: November 4, 2022
1.9K
China should emphasize key issues inherent in rational medication management for the elderly
Qi Tang1,2,3, Cao Wang1,2,3, Wenhui Wu1,2,3,4
1School of Public Health, Fudan University, Shanghai, China.
Bioscience Trends
|July 1, 2021
Summary
China
Area of Science:
- Gerontology
- Public Health
- Pharmaceutical Sciences
Background:
- China's population is rapidly aging, with over 18% aged 60+.
- Socioeconomic development and medical policies necessitate improved elderly medication management.
- Polypharmacy presents significant health risks for the aging population.
Purpose of the Study:
- To identify and discuss key challenges in rational medication management for China's elderly.
- To analyze factors contributing to medication-related risks in older adults.
- To propose recommendations for enhancing medication management and reducing polypharmacy.
Main Methods:
- Literature review and synthesis of current issues in elderly medication management in China.
- Analysis of contributing factors to polypharmacy and poor medication compliance.
- Discussion of pharmaceutical staffing and service awareness limitations.
Main Results:
- Identified five critical issues: serious polypharmacy, lack of consultation, poor compliance, staffing shortages, and low trust in pharmacists.
- Highlighted risks associated with unsupervised medication withdrawal and polypharmacy.
- Emphasized the need for improved pharmaceutical services and patient education.
Conclusions:
- Addressing these challenges is crucial for mitigating polypharmacy risks in China's elderly.
- Strengthening pharmaceutical services and pharmacist roles can improve medication safety.
- Policy interventions are needed to support rational medication management and reduce the elderly's disease burden.
More Related Videos
07:58Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
649
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.3K
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
55
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
55
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
55
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
55
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
39
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
39
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
101
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
101
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
42
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
42
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
39
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
39